Search results
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 3 hours agoThe US Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf) and Opuviz...
Are pet food recalls rising?
Newsweek· 2 hours agoPet food recalls have increased in recent years, according to U.S. Food and Drug Administration (FDA) records reviewed by Newsweek. The number of pet food-related recalls ...
FDA lifts hold on Larimar's Friedreich's Ataxia drug study By Investing.com
Investing.com· 8 hours agoLarimar Therapeutics, Inc. (NASDAQ:LRMR), a biotechnology firm engaged in developing treatments for...
FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma
Medscape· 7 hours agoThe US Food and Drug Administration (FDA) has announced the withdrawal of its 2021 accelerated approval of infigratinib (Truseltiq) for patients with a certain type of previously ...
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 7 hours agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
LDTs: FDA Rolls Out a Phased Implementation for New Regulatory Requirements
The National Law Review· 22 hours agoOn May 6, 2024, the U.S. Food and Drug Administration (FDA) issued its final rule significantly...
DentalMonitoring gains De Novo approval for orthodontic solution
Medical Device Network via Yahoo Finance· 3 hours agoDentalMonitoring has secured De Novo approval from the US Food and Drug Administration (FDA) for its...
Roche Breast Cancer Medicine to Get Expedited FDA Review
Bloomberg· 1 hour agoRoche Holding AG said an experimental breast-cancer treatment will get an expedited review from US...
FDA considers ban on device that delivers shocks to people with disabilities
WCVB Boston· 13 hours agoFood and Drug Administration is accepting comments until next week before deciding whether to try...
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance
WROC Rochester· 5 hours agoKS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type ...